Innate Pharma SA (IPHA) Free cash flow
Innate Pharma SA (IPHA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to IPHASource: SEC XBRL filings · For reference only · Not investment advice
More IPHA financial trends
IPHA RevenueIPHA Net incomeIPHA Net marginIPHA Gross profitIPHA Gross marginIPHA Operating incomeIPHA Operating marginIPHA Operating cash flowIPHA Capital expendituresIPHA Return on equityIPHA Stock buybacksIPHA Dividends paidIPHA Total assetsIPHA Total liabilitiesIPHA Shareholders’ equityIPHA overview →